Next-generation therapeutics

Pioneering therapies to improve women’s health

Using applied and original estrogen-based research, our targeted chemistry aims to drastically reduce the mental and physical effects of menopause.

Next-generation therapeutics

Leading the way in developing improved therapeutic technology for women

Using applied and original estrogen-based research, our targeted chemistry aims to drastically improve women’s health.

Women can live longer, healthier lives

Estrigenix Therapeutics, Inc. has the team and the technology
to make it happen.

Company Overview

Estrigenix Therapeutics, Inc. was formed in 2018 to improve women’s health, focusing initially on the physical and mental effects of menopause.

Technology

Leveraging deep expertise in estrogen biology, focused chemical libraries and associated intellectual property to address women’s health issues, Estrigenix technology concentrates on alleviating the symptoms of menopause without the risks of breast cancer and stroke associated with traditional hormone replacement therapy.

Team

Our team includes world experts in estrogen biology, medicinal chemistry and pharmacology, and an advisory board with extensive experience in the pharmaceutical industry, especially regarding the advancement of drugs through human clinical trials.

Estrigenix secures investment
from CU Ventures

CEO Donaldson receives award for Excellence in Research from Marquette University

Estrigenix presents at
2021 Early Stage Symposium

Estrigenix features in
MKE Startup News

Newsroom

See the latest news and updates from Estrigenix Therapeutics, Inc.

Estrigenix secures investment from CU Ventures

CEO Donaldson receives award for Excellence in Research from Marquette University

Estrigenix presents at 2021 Early Stage Symposium

Estrigenix features in MKE Startup News

Newsroom

See the latest news and updates from Estrigenix Therapeutics, Inc.

Our Partners

Our partners are key components to our success and growth as an organization.